Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial to Evaluate the Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers

NCT06182358 is registered in ClinicalTrials.gov with Tarsus Pharmaceuticals, Inc. as lead sponsor.

NCT NCT06182358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06182358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial to Evaluate the Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers
Lead sponsor
Tarsus Pharmaceuticals, Inc.
Phase
Phase 4
Overall status
Completed
Start date
December 27, 2023
Completion date
January 27, 2025
Enrollment
145 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

demodex blepharitis